News News
2022 - 08 - 19
On the evening of August 18, 2022, Kuancheng Technology held a symposium on gastrointestinal motility. The theme of the conference was 'Application of gastrointestinal motility detection and treatment in functional gastrointestinal diseases'.    In view of the lack of direct detection means and specific treatment of functional gastrointestinal diseases, we invited Professor Xiong Guanying from the Digestive Medicine Center of the Second Affiliated Hospital of Nanjing Medical University and Professor Jiang Liuqin from the Gastroenterology Department of Jiangsu Provincial People's Ho...
2022 - 07 - 15
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease characterized by abdominal pain, abdominal distension and abdominal discomfort accompanied by changes in defecation habits. It can seriously affect our work, study, life and mental health, and reduce the quality of life of patients. The prevalence of IBS in the general population was 1.4%-11.5%, which was slightly higher in women than in men. It was more common in young and middle-aged people (18-59 years old) and decreased in the elderly (≥60 years old).    Studies have found that IBS can be caused by a variety of...
2022 - 07 - 14
'Salt therapy' was recommended by the latest Chinese Expert Consensus on Pneumoconiosis and Lung Rehabilitation!Xinashu rock salt aerosol therapy - a new scheme for lung rehabilitation of pneumoconiosis patients  Pneumoconiosis is a disease mainly caused by diffuse fibrosis of lung tissue caused by long-term inhalation of productive mineral dust in occupational activities and retention in the lung. Generally speaking, most patients with early pneumoconiosis have no obvious symptoms and signs, and lung function has no obvious changes. With the progress of the disease, respiratory sympto...
2022 - 05 - 27
On May 26, 2022, Jiang Wei, deputy director of Jiangsu Drug Administration, visited our company (Nanjing Kuancheng Technology Co., LTD.) to carry out special research on the review and approval of Class II medical devices, accompanied by Mr. Tang Guangjian, Chairman of the board, Ms. Tang Shiwen, and Ms. Shen Xiaoling, vice general manager.    The investigation team visited our company's science and technology exhibition hall, R&D and production workshop, office area, etc., got an in-depth understanding of our company's medical devices, regional layout, equipment and facilities, an...
2022 - 05 - 25
Functional gastrointestinal diseases, accounting for more than 50% of gastroenterology outpatients. Such as abdominal bloating or flatulence, loss of appetite, early satiety, heartburn, hiccups, belching, anorexia, nausea, vomiting, acid reflux or food regurgitation, gastroparesis, indescribable epigastric discomfort, diarrhea, constipation and defecation difficulties and so on. In view of the above phenomenon, often need to rely on drugs to improve gastrointestinal function. However, drug therapy has great limitations, easy to produce drug resistance and side effects, and the treatment effect...
(National Service Hotline)
Copyright ©2018 - 2023 Nanjing Kuancheng Technology Co., Ltd
Be lenient towards others and be honest
Share to WeChat friends circle ×
Open WeChat and click "Discovery" at the bottom,
Use "Scan" to share pages with your friends.
Follow us: